{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001599298","name":"Summit Therapeutics Inc.","summary":"Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of oncology therapies. Its lead product candidate is ivonescimab, a novel bispecific antibody combining PD-1 immunotherapy blockade with anti-VEGF anti-angiogenesis effects into a single molecule. The company in-licensed ivonescimab from Akeso, Inc. in December 2022 and is pursuing clinical development including a BLA accepted for filing related to the HARMONi study.","people":[],"products":[{"name":"ivonescimab","type":"platform","description":"Novel potential first-in-class bispecific antibody combining PD-1 immunotherapy blockade and anti-VEGF anti-angiogenesis effects into a single molecule for oncology indications."}],"partnerships":[{"partner_name":"Akeso, Inc.","partnership_type":"licensing","description":"License Agreement signed December 5, 2022 granting Summit in-licensed intellectual property rights related to ivonescimab; Akeso also manufactures ivonescimab.","start_date":null}],"affiliations":[],"origin":{"leaf":"21da5e3b656c3ac3b59e88328d22e226539fe94ce487913ec0f352645497400b","parent":"7d1067b584d55902934538b5ff0734db223dad46e09e0ba9641d2cf95612cb77","timestamp":"2026-08-14T08:07:36.735Z","source":"0001599298-26-000015","chain":"SEC.gov PEM > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Hash this response content + parent + timestamp to reproduce the leaf hash","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin chain (see origin.leaf) traceable to an SEC-signed source. It is UNVERIFIED until validated.","how_to_validate":"GET https://origin.rootz.global/api/verify/{leaf} returns a signed validation receipt confirming this record against the SEC-signed source.","chain":"SEC.gov filing (government signature) then origin.rootz.global extraction then this response.","licensing":"Reading is free. Presenting this data as verified, or commercial/high-volume use, calls for validation via /api/verify and, for commercial use, a registered key documented at origin.rootz.global/dashboard.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"unverified — GET https://origin.rootz.global/api/verify/{leaf} for a signed validation receipt before citing","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}